Skyldberg B M, Murray E, Lambkin H, Kelehan P, Auer G U
Department of Oncology-Pathology, Cancer Center Karolinska, Huddinge Hospital, Karolinska Institute, Stockholm, Sweden.
Mod Pathol. 1999 Jul;12(7):675-82.
Paraffin-embedded samples from cervical adenocarcinomas, 19 cases from Irish patients and 19 cases from Swedish patients, were analyzed by polymerase chain reaction for the presence of infection with human papillomavirus (HPV). The results were compared with DNA ploidy, proliferation activity, and p53 and p21/WAF1 expression. The studies were performed to discover whether high-risk HPV infection in adenocarcinomas of the uterine cervix is associated with an increased proliferative activity and genomic instability. The results show that the majority (84.6%) of patients 59 years of age or younger showed HPV infection. The overall prevalence of HPV DNA was 60.5%, with the high-risk types, 16 and 18, the most frequent. HPV-16 had a prevalence of 23.7% (9 of 38), and HPV-18 had a prevalence of 26.3% (10 of 38). The HPV-positive tumors predominantly showed a tetraploid DNA distribution pattern, whereas HPV-negative tumors more frequently showed highly scattered aneuploid DNA profiles. Both HPV-positive and HPV-negative cases displayed high proliferative activity, as indicated by high Ki-67 and cyclin A immunoreactivity. Tumor suppressor gene analysis detected low p53 expression and high p21/WAF1 expression in HPV-positive patients and high p53 expression without simultaneously increased p21/WAF1 (indicative of mutated p53) in HPV-negative cases in the groups of women older than 59 years of age.
对来自爱尔兰患者的19例宫颈腺癌石蜡包埋样本和来自瑞典患者的19例宫颈腺癌石蜡包埋样本进行聚合酶链反应分析,以检测人乳头瘤病毒(HPV)感染情况。将结果与DNA倍体、增殖活性以及p53和p21/WAF1表达进行比较。开展这些研究是为了发现子宫颈腺癌中的高危HPV感染是否与增殖活性增加和基因组不稳定有关。结果显示,59岁及以下的患者中大多数(84.6%)存在HPV感染。HPV DNA的总体患病率为60.5%,高危型16和18最为常见。HPV-16的患病率为23.7%(38例中的9例),HPV-18的患病率为26.3%(38例中的10例)。HPV阳性肿瘤主要表现为四倍体DNA分布模式,而HPV阴性肿瘤更常表现为高度分散的非整倍体DNA谱。HPV阳性和阴性病例均显示出高增殖活性,高Ki-67和细胞周期蛋白A免疫反应性表明了这一点。肿瘤抑制基因分析在59岁以上女性组中检测到,HPV阳性患者p53表达低而p21/WAF1表达高,HPV阴性病例p53表达高且p21/WAF1未同时增加(表明p53突变)。